Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Strategies for an HIV vaccine
Norman L. Letvin
Norman L. Letvin
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):15-27. https://doi.org/10.1172/JCI15985.
View: Text | PDF
Perspective

Strategies for an HIV vaccine

  • Text
  • PDF
Abstract

Perspective

Authors

Norman L. Letvin

×

Total citations by year

Year: 2024 2018 2017 2016 2015 2013 2012 2011 2010 2008 2007 2006 2005 2004 2003 2002 Total
Citations: 1 1 1 1 1 1 2 1 1 1 2 1 3 4 3 4 28
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (28)

Title and authors Publication Year
HIV vaccination: Navigating the path to a transformative breakthrough—A review of current evidence
Scott GY, Worku D
Health Science Reports 2024
Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine
BJ Kim, BR Kim, YH Kook, BJ Kim
Frontiers in immunology 2018
Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses
BJ Kim, JR Gong, GN Kim, BR Kim, SY Lee, YH Kook, BJ Kim
Scientific Reports 2017
Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
C Zhao, Z Ao, X Yao
Human vaccines 2016
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost
SL Hulot, B Korber, EE Giorgi, N Vandergrift, KO Saunders, H Balachandran, LV Mach, MA Lifton, G Pantaleo, J Tartaglia, S Phogat, B Jacobs, K Kibler, B Perdiguero, CE Gomez, M Esteban, M Rosati, BK Felber, GN Pavlakis, R Parks, K Lloyd, L Sutherland, R Scearce, NL Letvin, MS Seaman, SM Alam, D Montefiori, HX Liao, BF Haynes, S Santra, RW Doms
Journal of virology 2015
Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies
Y Zhai, Z Zhong, M Zariffard, GT Spear, L Qiao
Vaccine 2013
Conservation of HIV-1 T cell epitopes across time and clades: Validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
L Levitz, OA Koita, K Sangare, MT Ardito, CM Boyle, J Rozehnal, K Tounkara, SM Dao, Y Koné, Z Koty, S Buus, L Moise, WD Martin, AS de Groot
Vaccine 2012
Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells
R Chapman, E Shephard, H Stutz, N Douglass, V Sambandamurthy, I Garcia, B Ryffel, W Jacobs, AL Williamson, TM Doherty
PloS one 2012
Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes
N Saubi, EJ Im, R Fernández-Lloris, O Gil, PJ Cardona, JM Gatell, T Hanke, J Joseph
Clinical & developmental immunology 2011
Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors
J Joseph, R Fernández-Lloris, E Pezzat, N Saubi, PJ Cardona, B Mothe, JM Gatell
Journal of biomedicine & biotechnology 2010
Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV
AS de Groot, DS Rivera, JA McMurry, S Buus, W Martin
Vaccine 2008
Induction of Potent CD8+ T-Cell Responses by Novel Biodegradable Nanoparticles Carrying Human Immunodeficiency Virus Type 1 gp120
X Wang, T Uto, T Akagi, M Akashi, M Baba
Journal of virology 2007
Rapid Memory CD8+ T-Lymphocyte Induction through Priming with Recombinant Mycobacterium smegmatis
AH Hovav, MJ Cayabyab, MW Panas, S Santra, J Greenland, R Geiben, BF Haynes, WR Jacobs, NL Letvin
Journal of virology 2007
Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env
MJ Cayabyab, AH Hovav, T Hsu, GR Krivulka, MA Lifton, DA Gorgone, GJ Fennelly, BF Haynes, WR Jacobs, NL Letvin
Journal of virology 2006
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection
J Encke, J Findeklee, J Geib, E Pfaff, W Stremmel
Clinical & Experimental Immunology 2005
Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses
KA Reimann, RA Parker, MS Seaman, K Beaudry, M Beddall, L Peterson, KC Williams, RS Veazey, DC Montefiori, JR Mascola, GJ Nabel, NL Letvin
Journal of virology 2005
Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses
X Chen, MT Rock, J Hammonds, J Tartaglia, A Shintani, J Currier, B Slike, JE Crowe, M Marovich, P Spearman
Journal of virology 2005
Progress on new vaccine strategies against chronic viral infections
JA Berzofsky, JD Ahlers, J Janik, J Morris, SK Oh, M Terabe, IM Belyakov
Journal of Clinical Investigation 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies
KR Young, BE Teal, Y Brooks, TD Green, JF Bower, TM Ross
AIDS Research and Human Retroviruses 2004
Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles
H Zhang, Y Huang, R Fayad, GT Spear, L Qiao
Journal of virology 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.
Young KR, Teal BE, Brooks Y, Green TD, Bower JF, Ross TM
AIDS Research and Human Retroviruses 2004
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines
WP Kong, Y Huang, ZY Yang, BK Chakrabarti, Z Moodie, GJ Nabel
Journal of virology 2003
Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4
TL Chang, CH Chang, DA Simpson, Q Xu, PK Martin, LA Lagenaur, GK Schoolnik, DD Ho, SL Hillier, M Holodniy, JA Lewicki, PP Lee
Proceedings of the National Academy of Sciences 2003
Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual
MJ Geels, M Cornelissen, H Schuitemaker, K Anderson, D Kwa, J Maas, JT Dekker, E Baan, F Zorgdrager, R van den Burg, M van Beelen, VV Lukashov, TM Fu, WA Paxton, L van der Hoek, SA Dubey, JW Shiver, J Goudsmit
Journal of virology 2003
Exploiting dentritic cells to improve efficacy
Ralph Steinmann, Melissa Pope
Journal of Clinical Investigation 2002
New directions in vaccine research
Peter Palese, Adolfo Garcia-Sastre
Journal of Clinical Investigation 2002
Influenza vaccines: Present and future
Peter Palese, Adolfo Garcia-Sastre
Journal of Clinical Investigation 2002
Cancer vaccines: progress reveals new complexities
Zhiya Yu, Nicholas Restifo
Journal of Clinical Investigation 2002

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts